Literature DB >> 23928190

Complex relationships of nicotinic receptor actions and cognitive functions.

Edward D Levin1.   

Abstract

Nicotine has been shown in a variety of studies to improve cognitive function including learning, memory and attention. Nicotine both stimulates and desensitizes nicotinic receptors, thus acting both as an agonist and a net antagonist. The relative roles of these two actions for nicotine-induced cognitive improvement have not yet been fully determined. We and others have found that acute nicotinic antagonist treatment can improve learning and attention. Nicotine acts on a variety of nicotinic receptor subtypes. The relative role and interactions of neuronal nicotinic receptor subtypes for cognition also needs to be better characterized. Nicotine acts on nicotinic receptors in a wide variety of brain areas. The role of some of these areas such as the hippocampus has been relatively well studied but other areas like the thalamus, which has the densest nicotinic receptor concentration are still only partially characterized. In a series of studies we characterized nicotinic receptor actions, anatomic localization and circuit interactions, which are critical to nicotine effects on the cognitive functions of learning, memory and attention. The relative role of increases and decreases in nicotinic receptor activation by nicotine were determined in regionally specific studies of the hippocampus, the amygdala, the frontal cortex and the mediodorsal thalamic nucleus with local infusions of antagonists of nicotinic receptor subtypes (α7 and α4β2). The understanding of the functional neural bases of cognitive function is fundamental to the more effective development of nicotinic drugs for treating cognitive dysfunction.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antagonist; Cognition; Desensitization; Nicotinic

Mesh:

Substances:

Year:  2013        PMID: 23928190      PMCID: PMC3797209          DOI: 10.1016/j.bcp.2013.07.021

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  73 in total

1.  Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

Authors:  A J Grottick; G A Higgins
Journal:  Behav Brain Res       Date:  2000-12-20       Impact factor: 3.332

2.  Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat.

Authors:  E D Levin
Journal:  Pharmacol Biochem Behav       Date:  1997-12       Impact factor: 3.533

Review 3.  Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.

Authors:  H Y Meltzer; P A Thompson; M A Lee; R Ranjan
Journal:  Neuropsychopharmacology       Date:  1996-03       Impact factor: 7.853

4.  Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala.

Authors:  Nii A Addy; Aya Nakijama; Edward D Levin
Journal:  Brain Res Cogn Brain Res       Date:  2003-03

5.  Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory.

Authors:  E D Levin; A Bradley; N Addy; N Sigurani
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.

Authors:  Morten S Thomsen; Ditte Z Christensen; Henrik H Hansen; John P Redrobe; Jens D Mikkelsen
Journal:  Neuropharmacology       Date:  2009-02-21       Impact factor: 5.250

7.  Nicotine enhances sustained attention in the rat under specific task conditions.

Authors:  N R Mirza; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  1998-08       Impact factor: 4.530

8.  Lobeline-induced learning improvement of rats in the radial-arm maze.

Authors:  Edward D Levin; Channelle N Christopher
Journal:  Pharmacol Biochem Behav       Date:  2003-08       Impact factor: 3.533

Review 9.  Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Authors:  Jerry J Buccafusco; J Warren Beach; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2008-11-20       Impact factor: 4.030

10.  Nicotinic receptors in the habenula: importance for memory.

Authors:  D Sanders; D Simkiss; D Braddy; S Baccus; T Morton; R Cannady; N Weaver; J E Rose; E D Levin
Journal:  Neuroscience       Date:  2009-12-24       Impact factor: 3.590

View more
  23 in total

1.  Smoking, psychiatric illness and the brain.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

Review 2.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

3.  Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.

Authors:  Alycia M Lee; Adrian C Arreola; Blake A Kimmey; Heath D Schmidt
Journal:  Behav Brain Res       Date:  2014-08-14       Impact factor: 3.332

Review 4.  Advances in Drug Discovery and Development in Geriatric Psychiatry.

Authors:  Alexander C Conley; Paul A Newhouse
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

Review 5.  Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.

Authors:  Jason A Gandelman; Paul Newhouse; Warren D Taylor
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

Review 6.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

Review 7.  Pharmacological analyses of learning and memory in zebrafish (Danio rerio).

Authors:  Jordan M Bailey; Anthony N Oliveri; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2015-03-17       Impact factor: 3.533

8.  Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder.

Authors:  Gerrit I Van Schalkwyk; Alan S Lewis; Zheala Qayyum; Kourtney Koslosky; Marina R Picciotto; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2015-09

9.  Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system.

Authors:  Li Wang; Luis E F Almeida; Nicholas A Spornick; Nicholas Kenyon; Sayuri Kamimura; Alfia Khaibullina; Mehdi Nouraie; Zenaide M N Quezado
Journal:  Psychopharmacology (Berl)       Date:  2015-09-04       Impact factor: 4.530

10.  Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.

Authors:  Yousef Tizabi; Bruk Getachew
Journal:  Clin Pharmacol Transl Med       Date:  2017-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.